Comprehensive genomic and molecular screening for breast and cervicalcancers.
At Labassure, we provide a focused portfolio of molecular and cytogenetic tests for female oncology, supporting the early detection, risk assessment, and personalized management of breast and cervical cancers—two of the most prevalent cancers affecting women globally. Our diagnostics are designed to guide both preventive and therapeutic decision-making through evidence-based genetic and biomarker analysis.
Offering genetic carrier screening and specialized tests to uncover underlying causes of recurrent pregnancy loss, and to assess risk factors for inherited conditions.
Ensuring maternal and fetal well-being through essential screenings, including early risk assessments and monitoring for key maternal health indicators during pregnancy.
